Yes, Novartis is a major global pharmaceutical leader actively engaged in the research, development, and commercialization of advanced cell and gene therapies. The company has pioneered breakthrough treatments in oncology and immunology, most notably developing groundbreaking chimeric antigen receptor T-cell (CAR-T) therapies like Kymriah, while continuing to invest heavily in next-generation manufacturing platforms and clinical trials for various genetic and autoimmune diseases.